Multiple Primary Malignancies in Patients With Gastric Cancer: A Retrospective Study in National Cancer Center of China
Cancer Innovation · 2026-06 · 5 (3)
DOI: 10.1002/cai2.70063 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Innovation, online erschienen am 12.05.2026. Verfasst von Guiling Zhu und 6 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Molecular Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital Chinese Academy of Me…. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Wu Jieping Medical Foundation.
Abstract (Originalsprache)
Background
Gastric cancer (GC) is a prevalent malignancy in China, posing significant health challenges. The persistently high tumor incidence and the rising number of tumor survivors may elevate the risk of multiple primary malignancies (MPMs) in GC patients.
Methods
We conducted a retrospective study involving 11,045 patients diagnosed with gastric adenocarcinoma at National Cancer Center of China between 2010 and 2017. A 6‐month interval distinguished synchronous MPMs (SMPMs) from metachronous MPMs (MMPMs).
Results
Of all GC patients, 443 (4.01%) had MPM, with 75.85% being males and an average age of 60 at initial diagnosis. Among the MPM cases, 415 (93.68%) had two primary cancers (53.98% synchronous and 46.02% metachronous), 27 (6.09%) had three, and 1 (0.23%) had four, totaling 472 extra gastric cancer sites. Esophageal, colorectal, and lung cancers were the most prevalent concomitant malignancies, with esophageal cancer more frequent in synchronous cases and breast cancer (observed only in females) more frequent in metachronous cases (both p < 0.001). In patients with two primary cancers, the SMPM subset included more males ( p < 0.001), with higher rates of smoking ( p = 0.012), alcohol consumption ( p < 0.001), and higher T stage at first diagnosis ( p < 0.001). The MMPM subset included more females ( p < 0.001), was younger at first diagnosis ( p < 0.001), and more frequently underwent surgery after first diagnosis ( p < 0.001).
Conclusions
MPM occurring in patients with GC predominantly involve the esophagus, colorectum, and lung. Elderly male patients with smoking or alcohol use represent a higher‐risk group and warrant vigilant surveillance. This study provides a clinical and epidemiologic basis for future research on MPM in GC.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- State Key Laboratory of Molecular Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital Chinese Academy of Medical Sciences and Peking Union Medical College Beijing China.
- Department of Clinical Laboratory Diagnostics, Beijing Friendship Hospital Capital Medical University Beijing China.
- Department of Pathology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital Chinese Academy of Medical Sciences and Peking Union Medical College Beijing China.
- Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital Chinese Academy of Medical Sciences and Peking Union Medical College Beijing China.
ORCID-Profile: Xiaobing Wang, Chunxia Du
Förderung
- Wu Jieping Medical Foundation
Zitieren
APA
Zhu, G., Li, Y., Wang, B., Xue, L., Jiao, Y., Wang, X., & Du, C. (2026). Multiple Primary Malignancies in Patients With Gastric Cancer: A Retrospective Study in National Cancer Center of China. Cancer Innovation, 5(3). https://doi.org/10.1002/cai2.70063
Vancouver
Zhu G, Li Y, Wang B, Xue L, Jiao Y, Wang X, et al. Multiple Primary Malignancies in Patients With Gastric Cancer: A Retrospective Study in National Cancer Center of China. Cancer Innovation. 2026;5(3). doi:10.1002/cai2.70063
BibTeX
@article{Zhu2026,
author = {Zhu, Guiling and Li, Yutong and Wang, Bingzhi and Xue, Liyan and Jiao, Yuchen and Wang, Xiaobing and Du, Chunxia},
title = {Multiple Primary Malignancies in Patients With Gastric Cancer: A Retrospective Study in National Cancer Center of China},
journal = {Cancer Innovation},
year = {2026},
volume = {5},
number = {3},
doi = {10.1002/cai2.70063}
}
EUVIMED